Post-stereotactic surgery
Showing 1 - 25 of >10,000
Brain Metastases, Adult Trial in Heidelberg (post-operative stereotactic radiosurgery (SRS), Whole brain radiotherapy (WBRT))
Completed
- Brain Metastases, Adult
- post-operative stereotactic radiosurgery (SRS)
- Whole brain radiotherapy (WBRT)
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
Nov 2, 2022
Metastatic Malignant Tumor in the Brain Trial (procedure, other, radiation)
Not yet recruiting
- Metastatic Malignant Neoplasm in the Brain
- Brain Surgery
- +3 more
- (no location specified)
Jun 24, 2022
Spine Metastases Trial (Spondylectomy, SBRT)
Not yet recruiting
- Spine Metastases
- Spondylectomy
- SBRT
- (no location specified)
Aug 10, 2022
Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in Scottsdale, Jacksonville, Rochester (procedure, other,
Recruiting
- Malignant Solid Neoplasm
- Metastatic Malignant Neoplasm in the Brain
- Conventional Surgery
- +3 more
-
Scottsdale, Arizona
- +2 more
Feb 2, 2022
Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,
Recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Brain Metastases Trial in Calgary, Edmonton (Brain Surgery, Stereotactic Radiosurgery)
Recruiting
- Brain Metastases
- Brain Surgery
- Stereotactic Radiosurgery
-
Calgary, Alberta, Canada
- +1 more
Sep 28, 2021
Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)
Not yet recruiting
- Recurrent Prostate Cancer After Surgery
- Daily-adaptive Stereotactic Body Radiation Therapy
-
Rochester, New YorkWilmot Cancer Institute - Dept of Radiation Oncology
Jul 7, 2023
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- stereotactic body radiation therapy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in
Recruiting
- Stage I Non-Small Cell Lung Cancer AJCC v7
- +6 more
- Laboratory Biomarker Analysis
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Malignant Tumor, Brain, Brain Tumor Trial in Los Angeles (other, radiation, procedure)
Withdrawn
- Malignant Neoplasm, Brain
- Brain Tumor
- Quality-of-Life Assessment
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 14, 2022
Colorectal Cancer Trial in Strasbourg (Intraoperative acquisition (robotic c-Arm) of images)
Recruiting
- Colorectal Cancer
- Intraoperative acquisition (robotic c-Arm) of images
-
Strasbourg, FranceService de Chirurgie Digestive et Endocrinienne, NHC
Aug 18, 2022
Prostate Cancer Trial in Toronto (stereotactic body radiotherapy (SBRT))
Recruiting
- Prostate Cancer
- stereotactic body radiotherapy (SBRT)
-
Toronto, Onatrio, CanadaSunnybrook Cancer center
Oct 25, 2022
Lung Tumor Malignant Trial in Milano (SBRT, Surgery)
Not yet recruiting
- Lung Neoplasm Malignant
- SBRT
- Surgery
-
Milano, MI, ItalyIstituto Europeo di Oncologia IRCCS
Jul 26, 2023
Malignant Prostate Tumor Trial in Rochester (procedure, radiation, other)
Not yet recruiting
- Malignant Prostate Neoplasm
- Computed Tomography
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 13, 2023
Breast Cancer Trial in Birmingham (Single Fraction Stereotactic Body Radiation Therapy)
Recruiting
- Breast Cancer
- 1-3 Fraction Stereotactic Body Radiation Therapy
-
Birmingham, AlabamaUniversity of Alabama at Birmingham (UAB) Hazelrig-Salter Radiat
Jan 23, 2023
Carcinoma, Non-Small-Cell-Lung, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (European Organization for Research and
Completed
- Carcinoma, Non-Small-Cell-Lung
- +2 more
- European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 6, 2021
Lung Tumor Trial in United States (Stereotactic Radiotherapy, Anatomic Pulmonary Resection)
Recruiting
- Lung Neoplasm
- Stereotactic Radiotherapy
- Anatomic Pulmonary Resection
-
Long Beach, California
- +16 more
Sep 9, 2022
Breast Cancer, Breast Cancer Female, Breast Adenocarcinoma Trial in Tampa (Standard of Care Schedule Variation: SABR,
Terminated
- Breast Cancer
- +2 more
- Standard of Care Schedule Variation: SABR
- Breast-conserving Surgery
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Apr 26, 2022
Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body
Completed
- Recurrent Non-small Cell Lung Cancer
- +3 more
- therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
- quality-of-life assessment
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)
Not yet recruiting
- Brain Metastases
- Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
- Stereotactic Radiation Therapy
- (no location specified)
Jun 2, 2023
Head Neck Cancer Trial in Pittsburgh (Stereotactic Body Radiotherapy)
Completed
- Head and Neck Cancer
- Stereotactic Body Radiotherapy
-
Pittsburgh, PennsylvaniaUPMC Shadyside Radiation Oncology
Dec 16, 2021
Intracranial Hemorrhage, Hypertensive Trial in Beijing (Endoscopic Evacuation, Stereotactic Aspiration, Craniotomy)
Completed
- Intracranial Hemorrhage, Hypertensive
- Endoscopic Evacuation
- +2 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 16, 2022
Hepatocellular Carcinoma Trial in Lille (Surgery with Neoadjuvant stereotactic body radiation therapy)
Recruiting
- Hepatocellular Carcinoma
- Surgery with Neoadjuvant stereotactic body radiation therapy
-
Lille, FranceHop Claude Huriez Chu Lille
Jul 4, 2022
Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic
Recruiting
- Pancreas Adenocarcinoma
- Resectable Pancreatic Cancer
- Gemcitabine 1000 mg
- +2 more
-
Loma Linda, CaliforniaLoma Linda University Health
Jun 14, 2022
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage
Active, not recruiting
- Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 7, 2021